Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Fortaleciendo las conexiones con las oportunidades de participación en la prevención (SCOPE)

25 de septiembre de 2026 actualizado por: Kevin Borrup

Fortalecimiento de las conexiones con las oportunidades de participación en la prevención (SCOPE)

The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) in an effort to reduce levels of violence exposure.

Descripción general del estudio

Estado

Activo, no reclutando

Descripción detallada

The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) when they are determined to have high levels of violence exposure.

SCOPE seeks to decrease future violence exposure and increase resiliency of children with high levels of exposure to violence through Emergency Department (ED)-based case management and connections with community partners.

Hypothesis 1: VPET scores within the intervention group will show significant reductions across the study period. The percent of patients with positive VPET positive scores within the intervention group will show significant reductions from the expected 79% to 70% as compared to the control group that will have the expected 79%

Hypothesis 2: The Child and Youth Resilience Measure-Revised (CYRM) scores for the intervention group will increase by 10%, and will be significantly higher than the control group.

Hypothesis 3: At least 75% of the intervention group will be assessed as "positive" for having made a connection with community services.

Hypothesis 4: 90% of parents with children receiving case management will report being satisfied with the case management services and community connected services.

Hypothesis 5: Retention within the intervention group will be at or above 50%, with at least half of participants remaining engaged in the project.

Hypothesis 6: Compared to the control group, the intervention group will have fewer documented injuries and ED visits during the 12-month period post-enrollment.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

225

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Connecticut
      • Hartford, Connecticut, Estados Unidos, 06106
        • Connecticut Children's

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

8 años a 17 años (Niño)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • At least 8 years of age and not older than 17 years of age (until 18th birthday)
  • Hartford resident based on zip code of primary residence or parent report?
  • Accompanied by a parent or guardian who can provide consent
  • Capable of providing assent/consent
  • Able to provide consent in English or Spanish
  • Presenting at CT Children's during recruitment hours

Exclusion Criteria:

  • Patients whose primary complaint is for behavioral health
  • Patients in Connecticut Department of Children and Families (DCF) or police custody

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Intervention

Enrolled subjects will provide the study team with email, mobile, work phone, physical contact address, and contact numbers for two or more close contacts. Families will be contacted monthly by the case manager assist with additional supports they might need. Quarterly, patients and families will be contacted and patients will be asked to complete VPET and other measures. The intervention group will receive active case management to connect affected youth to community services.

A case manager will work with families post-discharge to ensure that youth are connected to an appropriate community support. Case managers will also work with families to identify any social needs and provide support in accessing services as needed.

Subjects will receive a list of youth serving community service agencies and provided a recommendation to connect to them.

Comparador activo: Treatment as Usual

The comparison group will receive treatment as usual which consists of a list of community resources and a recommendation that youth not already connected with a community service provider be connected.

Subjects will receive a list of youth serving community service agencies and provided a recommendation to connect to them.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change from baseline violence exposure at 12 months
Periodo de tiempo: Baseline and months 3, 6, 9, and 12

A reduction in exposure as measured using the Violence Prevention Emergency Tool (VPET) that provides a range from 0 to 21 with a 4 or more considered elevated.

Baseline and months 3, 6, 9, and 12

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in resilience score from baseline at 12 months
Periodo de tiempo: Baseline and months 3, 6, 9, and 12

The Child and Youth Resilience Measure-Revised (CYRM) is a validated scale with resilience scores that range from 17 to 85 with a higher score indicating greater resilience.

Baseline and months 3, 6, 9, and 12
Difference in connections between intervention and control at 3-month intervals.
Periodo de tiempo: Quarterly measure at 0, 3, 6, 9, and 12 months

A dichotomous yes/no variable answering the question of are you currently connected to services at a community agency?

Quarterly measure at 0, 3, 6, 9, and 12 months
Level of satisfaction with case management services after 12 months of services
Periodo de tiempo: At 12-months of case management.

Level of satisfaction with case management services as indicated along a 5-point scale from Not satisfied to Completely satisfied. Higher levels of satisfaction are related with other improved outcomes from baseline.

At 12-months of case management.
Rate of re-injury in the intervention group compared to the control condition.
Periodo de tiempo: baseline, 3, 6, 9, 12 months

Hospital documented injuries during the study period will be assessed on a quarterly schedule.

baseline, 3, 6, 9, 12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: Kevin Borrup, DrPH, Connecticut Children's

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

19 de agosto de 2024

Finalización primaria (Estimado)

30 de agosto de 2027

Finalización del estudio (Estimado)

30 de septiembre de 2027

Fechas de registro del estudio

Enviado por primera vez

29 de mayo de 2024

Primero enviado que cumplió con los criterios de control de calidad

29 de mayo de 2024

Publicado por primera vez (Actual)

4 de junio de 2024

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

28 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

25 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • 24-052

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir